Browse by Content Type

Developing a Strategic Plan for CAR Cell Therapy Programs

A global pharmaceutical company sought a strategic plan to guide its CAR cell therapy program, exploring both CAR-T and CAR-NK platforms. Arya facilitated working sessions, conducted primary research, and validated insights to develop a go-to-market roadmap aligned with leadership goals.

Building a Robust US Forecast Model for a Rare Disease Therapy

A biopharmaceutical company needed a US forecast model for a rare disease therapy. Arya assessed analog case studies, aligned stakeholder assumptions, and delivered a customizable model that reflected real-world dynamics—enhancing decision-making and scenario planning.

Executing Global Value Clinic 2.0 for a Market Access Team

A pharmaceutical company sought to evolve its Global Value Clinic to address value drivers, knowledge gaps, and stakeholder insights. Arya designed and executed Value Clinic 2.0, fostering alignment on asset value differentiators and driving cross-functional collaboration.

Conducting Situational Analyses to Inform Oncology Asset Strategy

A global pharmaceutical company needed a deep understanding of six tumor types for a novel oncology asset. Arya conducted situational analyses, competitor assessments, and market evaluations to inform commercial and development strategies.

Prioritizing Indication Opportunities for an Oncology Asset

A global pharmaceutical company needed to prioritize indications for a pipeline oncology asset. Arya built a structured evaluation framework, aligned criteria, and delivered a prioritized list of opportunities—maximizing asset value and development focus.

Developing an Integrated Global Brand Plan for an Ophthalmology Asset

A pharmaceutical company needed support updating its global brand plan for an ophthalmology asset. Arya conducted working sessions, facilitated sprint workshops, and created a situational analysis and iSWOT to finalize a robust FY2025 plan.

Launch Readiness and Cross-Functional Planning for a Dual-Tumor Asset

Preparing for a second-indication launch, a pharmaceutical company needed a global launch plan for a dual-tumor asset. Arya facilitated a hybrid global workshop, created launch kits, and consolidated 300+ activities into a cohesive plan.

Lifecycle Management (LCM) Planning for a Joint Oncology Asset

Two pharmaceutical companies needed a joint LCM plan for their oncology asset. Arya conducted workshops, analyzed 250+ sources, and developed a Global Product Blueprint to align both organizations on future opportunities.

Competitor Strategy and Counter-Strategy Workshops for a Women’s Health Product

A pharmaceutical company faced new competition in the women’s health space. Arya designed and facilitated competitor strategy workshops, developed briefing materials, and captured key insights to inform commercial counter-strategies.

Creating a Value Proposition to Increase Diagnosis Rates for a Rare Cardiac Disease

To increase diagnosis rates for a rare cardiac disease, Arya developed a value proposition and field resources to educate HCPs and Health System Administrators. Arya also supported post-launch efforts to keep the field team informed.

Developing a Cross-Functional iEGP to Support EMA Submission for an Ophthalmology Asset

A pharmaceutical company sought to develop an integrated evidence generation plan (iEGP) to support EMA submission and future product uptake. Arya facilitated workshops and created a multi-year iEGP to address prioritized evidence gaps.

Creating a Multi-Year iEGP to Support Long-Term Growth of an Ophthalmology Asset

To strengthen future growth, a pharmaceutical company needed a longer-term iEGP for an ophthalmology asset. Arya led virtual workshops and developed a comprehensive plan to address stakeholder-driven evidence gaps and guide future research.

Building a Global Scientific Communications Platform for an Ophthalmology Asset

A pharmaceutical company partnered with Arya to develop a unified Scientific Communications Platform (SCP) for its ophthalmology asset. Arya facilitated virtual workshops and refined messages to align cross-functional teams.

Developing an HCP Segmentation Framework to Drive Adoption of a Cell Therapy Product

A pharmaceutical company launching its first cell therapy needed a data-driven HCP segmentation framework. Arya combined qualitative and quantitative insights to develop actionable segments and optimize engagement strategies.

Enhancing Team Collaboration Through a Dynamic Publication Repository

A pharmaceutical company needed to enhance internal awareness of key publications. Arya developed a dynamic, Excel-based publication repository with filtering and search capabilities to improve cross-functional collaboration.

Developing a Global Value Strategy Plan for a Prostate Cancer Asset

A pharmaceutical company needed to update its global value strategy for a prostate cancer asset nearing the end of its lifecycle. Arya facilitated workshops, synthesized insights, and developed a comprehensive value plan aligned with commercial and HEOR objectives.

Building a Payer Value Proposition for a COVID-19 Anti-Viral Product

A pharmaceutical company required a Payer Value Proposition (PVP) to support market access and reimbursement for a COVID-19 anti-viral product. Arya created a cross-functionally aligned PVP that strengthened market positioning and streamlined HTA assessments.

Executing Wargaming Workshops to Prepare for Market Competitors

A pharmaceutical company sought to anticipate competitive threats for a rare cardiac disease product. Arya conducted scenario-based wargaming workshops, developed action plans, and enabled the client to exceed market retention goals post-launch.

Creating a Global Value Toolkit for Oncology Assets

A pharmaceutical company needed a consolidated market access resource for two oncology assets. Arya developed a Global Value Toolkit that aligned cross-functional teams and streamlined market access, HEOR, and pricing strategies.

Facilitating Value Clinics to Incorporate Payer Perspectives in Asset Development

A pharmaceutical company needed to integrate payer perspectives in early asset development. Arya designed and facilitated value clinics that aligned cross-functional teams on key value drivers, evidence gaps, and future payer research questions.

Driving Enterprise-Wide Data Governance Adoption at a Leading Insurance Firm

A top U.S. insurance firm needed to establish a data governance framework to comply with regulations like CCPA. Arya developed a phased adoption plan, led change management workshops, and trained cross-functional teams to ensure seamless adoption.

Establishing a Franchise Blueprint for a Newly Integrated Therapeutic Area

A pharmaceutical company sought to align its newly integrated ophthalmology and rare disease franchise. Arya facilitated workshops, aligned workstreams, and developed scorecards and KPIs to guide commercialization efforts.

Transforming Global Marketing Strategy Through Team Integration

A pharmaceutical company integrated regional marketing functions into the global strategy team. Arya defined roles, streamlined processes, and executed a change management plan to enable smooth transformation and alignment.

Mobilizing Agile Task Forces to Refocus Brand Positioning and Messaging

A pharmaceutical company needed to refocus its brand positioning and messaging for an antipsychotic product. Arya mobilized agile task forces, facilitated workshops, and developed communication plans to ensure organizational alignment.

Developing Competency Models to Align Talent with Organizational Goals

A pharmaceutical company wanted to develop competency models for Commercial and Medical Affairs teams. Arya conducted best-practice analysis, built developmental frameworks, and designed curriculum maps to empower talent growth.

Driving AI Readiness with an Enterprise Data Strategy

A PE-backed ed-tech firm needed a data strategy to unify data and enable AI. Arya consolidated data ecosystems, established governance frameworks, and enabled AI adoption—enhancing decision-making and ensuring seamless integration with future acquisitions.

Enabling Underwriting and Service Innovation with a Robust AI Strategy

An insurance firm needed a comprehensive AI strategy to improve underwriting and service operations. Arya integrated machine learning for underwriting and generative AI for customer service—boosting efficiency and streamlining processes.

Restoring Trust in Data

A real estate leader struggled with fragmented data silos and inconsistent reporting. Arya implemented Snowflake, Fivetran, and DBT to consolidate data and enable certified reporting—reducing manual effort, eliminating spreadsheet dependencies, and restoring trust in data insights.

Driving E-Commerce Growth with AI-Driven Recommendations and Customer Insights

A global e-commerce leader struggled to personalize experiences. Arya deployed an AI-powered recommendation engine and sentiment analysis to deliver personalized recommendations, increasing conversion rates by 25% and boosting retention by 30%.

Preventing Fraud and Minimizing False Positives with AI

A financial services firm faced increasing fraud threats and false positives. Arya implemented AI-based fraud detection models to enhance security—reducing false positives by 40% and safeguarding transactions.

Insights & Signals

Where Expertise Meets Actions

Featured Highlights

Case Studies

Driving AI Readiness with an Enterprise Data Strategy

Case Studies

Establishing a Franchise Blueprint for a Newly Integrated Therapeutic Area

Case Studies

Building a Global Scientific Communications Platform for an Ophthalmology Asset

Case Studies

Creating a Global Value Toolkit for Oncology Assets

Case Studies

Prioritizing Indication Opportunities for an Oncology Asset

Case Studies

Developing an Integrated Global Brand Plan for an Ophthalmology Asset

Browse by Content Type

Developing a Strategic Plan for CAR Cell Therapy Programs

Building a Robust US Forecast Model for a Rare Disease Therapy

Executing Global Value Clinic 2.0 for a Market Access Team

Conducting Situational Analyses to Inform Oncology Asset Strategy

Prioritizing Indication Opportunities for an Oncology Asset

Developing an Integrated Global Brand Plan for an Ophthalmology Asset

Launch Readiness and Cross-Functional Planning for a Dual-Tumor Asset

Lifecycle Management (LCM) Planning for a Joint Oncology Asset

Competitor Strategy and Counter-Strategy Workshops for a Women’s Health Product

Creating a Value Proposition to Increase Diagnosis Rates for a Rare Cardiac Disease

Developing a Cross-Functional iEGP to Support EMA Submission for an Ophthalmology Asset

Creating a Multi-Year iEGP to Support Long-Term Growth of an Ophthalmology Asset

Building a Global Scientific Communications Platform for an Ophthalmology Asset

Developing an HCP Segmentation Framework to Drive Adoption of a Cell Therapy Product

Enhancing Team Collaboration Through a Dynamic Publication Repository

Developing a Global Value Strategy Plan for a Prostate Cancer Asset

Building a Payer Value Proposition for a COVID-19 Anti-Viral Product

Executing Wargaming Workshops to Prepare for Market Competitors

Creating a Global Value Toolkit for Oncology Assets

Facilitating Value Clinics to Incorporate Payer Perspectives in Asset Development

Driving Enterprise-Wide Data Governance Adoption at a Leading Insurance Firm

Establishing a Franchise Blueprint for a Newly Integrated Therapeutic Area

Transforming Global Marketing Strategy Through Team Integration

Mobilizing Agile Task Forces to Refocus Brand Positioning and Messaging

Developing Competency Models to Align Talent with Organizational Goals

Driving AI Readiness with an Enterprise Data Strategy

Enabling Underwriting and Service Innovation with a Robust AI Strategy

Restoring Trust in Data

Driving E-Commerce Growth with AI-Driven Recommendations and Customer Insights

Preventing Fraud and Minimizing False Positives with AI

Stay Connected